Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 161

1.

Normalization of the microbiota in patients after treatment for colonic lesions.

Sze MA, Baxter NT, Ruffin MT 4th, Rogers MAM, Schloss PD.

Microbiome. 2017 Nov 16;5(1):150. doi: 10.1186/s40168-017-0366-3.

2.

The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity.

Djuric Z, Turgeon DK, Sen A, Ren J, Herman K, Ramaswamy D, Zhao L, Ruffin MT 4th, Normolle DP, Smith WL, Brenner DE.

Cancer Prev Res (Phila). 2017 Nov 13. doi: 10.1158/1940-6207.CAPR-17-0091. [Epub ahead of print]

PMID:
29133307
3.

Correlates of Risky Alcohol Use Among Women from Appalachian Ohio.

Tzilos GK, Hade EM, Ruffin MT, Paskett ED.

Rural Ment Health. 2017;41(2):152-161. doi: 10.1037/rmh0000067. Epub 2017 Jun 8.

PMID:
29085525
4.

The Effect of Perceived Stress on Epstein-Barr Virus Antibody Titers in Appalachian Ohio Women.

Brook MJ, Christian LM, Hade EM, Ruffin MT.

Neuroimmunomodulation. 2017;24(2):67-73. doi: 10.1159/000478658. Epub 2017 Sep 22.

PMID:
28934729
5.

Diet and exercise changes following direct-to-consumer personal genomic testing.

Nielsen DE, Carere DA, Wang C, Roberts JS, Green RC; PGen Study Group.

BMC Med Genomics. 2017 May 2;10(1):24. doi: 10.1186/s12920-017-0258-1.

6.

Correlates of Patient Intent and Preference on Colorectal Cancer Screening.

Jimbo M, Sen A, Plegue MA, Hawley ST, Kelly-Blake K, Rapai M, Zhang M, Zhang Y, Ruffin MT 4th.

Am J Prev Med. 2017 Apr;52(4):443-450. doi: 10.1016/j.amepre.2016.11.026. Epub 2017 Feb 3.

PMID:
28169019
7.

Effects of an Education Intervention about HPV Self-Testing for Healthcare Providers and Staff.

Presser BE, Katz ML, Shoben AB, Moore D, Ruffin MT, Paskett ED, Reiter PL.

J Cancer Educ. 2017 Jan 10. doi: 10.1007/s13187-017-1164-0. [Epub ahead of print]

PMID:
28074444
8.

Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results.

Roberts JS, Gornick MC, Carere DA, Uhlmann WR, Ruffin MT, Green RC.

Public Health Genomics. 2017;20(1):36-45. doi: 10.1159/000455006. Epub 2017 Jan 10.

PMID:
28068660
9.

Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.

Gray SW, Gollust SE, Carere DA, Chen CA, Cronin A, Kalia SS, Rana HQ, Ruffin MT 4th, Wang C, Roberts JS, Green RC.

J Clin Oncol. 2017 Feb 20;35(6):636-644. doi: 10.1200/JCO.2016.67.1503. Epub 2016 Dec 12.

10.

DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.

Baxter NT, Koumpouras CC, Rogers MA, Ruffin MT 4th, Schloss PD.

Microbiome. 2016 Nov 14;4(1):59.

11.

Colonic Saturated Fatty Acid Concentrations and Expression of COX-1, but not Diet, Predict Prostaglandin E2 in Normal Human Colon Tissue.

Sidahmed E, Sen A, Ren J, Patel A, Turgeon DK, Ruffin MT, Brenner DE, Djuric Z.

Nutr Cancer. 2016 Oct;68(7):1192-201. doi: 10.1080/01635581.2016.1213866. Epub 2016 Aug 22.

12.

Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions.

Baxter NT, Ruffin MT 4th, Rogers MA, Schloss PD.

Genome Med. 2016 Apr 6;8(1):37. doi: 10.1186/s13073-016-0290-3.

13.

Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing.

van der Wouden CH, Carere DA, Maitland-van der Zee AH, Ruffin MT 4th, Roberts JS, Green RC; Impact of Personal Genomics Study Group.

Ann Intern Med. 2016 Apr 19;164(8):513-22. doi: 10.7326/M15-0995. Epub 2016 Mar 1.

PMID:
26928821
14.

Explaining, not just predicting, drives interest in personal genomics.

Meisel SF, Carere DA, Wardle J, Kalia SS, Moreno TA, Mountain JL, Roberts JS, Green RC; PGen Study Group.

Genome Med. 2015 Aug 1;7(1):74. doi: 10.1186/s13073-015-0188-5. eCollection 2015.

15.

No evidence in US of HPV16/18 cancer precursor reduction.

Pendleton ME, Ruffin MT 4th, Harper DM.

Vaccine. 2016 Jan 4;34(2):200. doi: 10.1016/j.vaccine.2015.07.047. Epub 2015 Jul 29. No abstract available.

PMID:
26232544
16.

How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study.

Ostergren JE, Gornick MC, Carere DA, Kalia SS, Uhlmann WR, Ruffin MT, Mountain JL, Green RC, Roberts JS; PGen Study Group.

Public Health Genomics. 2015;18(4):216-24. doi: 10.1159/000431250. Epub 2015 Jun 16.

17.

Prompting Primary Care Providers about Increased Patient Risk As a Result of Family History: Does It Work?

Zazove P, Plegue MA, Uhlmann WR, Ruffin MT 4th.

J Am Board Fam Med. 2015 May-Jun;28(3):334-42. doi: 10.3122/jabfm.2015.03.140149.

18.

Impact of an Electronic Health Record (EHR) Reminder on Human Papillomavirus (HPV) Vaccine Initiation and Timely Completion.

Ruffin MT 4th, Plegue MA, Rockwell PG, Young AP, Patel DA, Yeazel MW.

J Am Board Fam Med. 2015 May-Jun;28(3):324-33. doi: 10.3122/jabfm.2015.03.140082.

19.

Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study.

Umoh FI, Kato I, Ren J, Wachowiak PL, Ruffin MT 4th, Turgeon DK, Sen A, Brenner DE, Djuric Z.

Eur J Nutr. 2016 Mar;55(2):793-798. doi: 10.1007/s00394-015-0900-7. Epub 2015 Apr 24.

20.

Impact of family history assessment on communication with family members and health care providers: A report from the Family Healthware™ Impact Trial (FHITr).

Wang C, Sen A, Plegue M, Ruffin MT 4th, O'Neill SM, Rubinstein WS, Acheson LS; Family Healthware™ Impact Trial (FHITr) Group; Family Healthware Impact Trial FHITr Group.

Prev Med. 2015 Aug;77:28-34. doi: 10.1016/j.ypmed.2015.04.007. Epub 2015 Apr 19.

Supplemental Content

Loading ...
Support Center